Observation of curative effect regarding corneal cross-linking treatment of riboflavin combined with 440 nm blue-light cornea for fungal keratitis
نویسندگان
چکیده
To observe and analyze the curative effects of the treatment of riboflavin combined with 440 nm blue-light corneal cross-linking (CXL) treatment for fungal keratitis via a rabbit model experiment. A model of rabbit fungal keratitis was used through anterior stromal injection in which 24 rabbits were randomly divided into blank control, 360 nm group, and 440 nm group. Both groups underwent CXL treatment. Ultraviolet radiation A (365 nm) and blue-light (440 nm) irradiations were performed for 30 min after 30 min of 0.1% riboflavin eye drops used in 360 nm and 440 nm groups, respectively. Slit-lamp observation, photography of the cornea, calculation of ulcer area, and comparison of examination under confocal microscope were performed for all rabbits on the first, third, and seventh days after treatment. No statistical significance was observed between all groups on the first day after treatment (P>0.05). In 3 days after surgery, the cornea ulcer area decreased by 35.65% in the 360 group (P=0.012) and 37.94% in the 440 group (P=0.015), thus the two groups showing no statistical significance (P=0.88). In 7 days after surgery, the area vanished by 59.02% in the 360 group (P=0.00) and 55.29% in the 440 group (P=0.001), thus the two groups showing statistical significance (P=0.75). Riboflavin with 440 nm blue-light irradiation had a positive effect on treatment for fungal keratitis.
منابع مشابه
Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis
BACKGROUND Fungal keratitis is one of the major causes of visual impairment worldwide. However, the effectiveness of corneal collagen cross-linking (CXL) for fungal keratitis remains controversial. In this study, we developed an in vitro and an in vivo models to assess the efficacy of CXL for Fusarium keratitis. METHODS The effect of in vitro CXL fungicidal was evaluated on the cultures of Fu...
متن کاملPACK-CXL: Corneal cross-linking in infectious keratitis.
BACKGROUND Corneal cross-linking (CXL) using ultraviolet light-A (UV-A) and riboflavin is a technique developed in the 1990's to treat corneal ectatic disorders such as keratoconus. It soon became the new gold standard in multiple countries around the world to halt the progression of this disorder, with good long-term outcomes in keratometry reading and visual acuity. The original Dresden treat...
متن کاملCorneal Collagen Cross-Linking Using Riboflavin and Ultraviolet-A Irradiation in Keratitis Treatment
Cross-linking is a common method of tissue stabilization. For example, cross-linking is used for formaldehyde-induced tissue stiffening and fixation in pathologic specimens. Corneal collagen Crosslinking (CXL) is performed with ultraviolet-A (UVA) irradiation at 370 nm and the photosensitizer riboflavin (vitamin B2). According to Wollensak (Wollensak, 2006), the photosensitizer is excited into ...
متن کاملCorneal cross-linking.
Since its inception in the late 1990s, corneal cross-linking has grown from an interesting concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of ultraviolet-A light and a chromophore (vitamin B2, riboflavin), the cornea can be stiffened, usually with a single application, and progressive thinning diseases such as keratoconus arrested. Despite being in clin...
متن کاملCollagen Cross-linking for Microbial Keratitis
Collagen cross-linking is gaining popularity not only for arresting the progression of keratoconus but also other indications including management of corneal infections. In this review article, we analyzed the published literature to understand the level of evidence for its use in corneal ulcer. Photoactivated riboflavin and ultraviolet A light are known to possess antimicrobial properties. The...
متن کامل